These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15026340)

  • 1. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
    Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
    Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
    Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
    Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
    Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
    J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
    Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
    Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
    Shi Q; Le X; Abbruzzese JL; Peng Z; Qian CN; Tang H; Xiong Q; Wang B; Li XC; Xie K
    Cancer Res; 2001 May; 61(10):4143-54. PubMed ID: 11358838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
    Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
    Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis.
    Gao Y; Jia Z; Kong X; Li Q; Chang DZ; Wei D; Le X; Suyun H; Huang S; Wang L; Xie K
    Cancer Res; 2011 Aug; 71(15):5182-93. PubMed ID: 21673052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib can induce vascular endothelial growth factor expression and tumor angiogenesis.
    Xu K; Gao H; Shu HK
    Mol Cancer Ther; 2011 Jan; 10(1):138-47. PubMed ID: 21220497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
    Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
    Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
    Loeffler S; Fayard B; Weis J; Weissenberger J
    Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
    Abdelrahim M; Safe S
    Mol Pharmacol; 2005 Aug; 68(2):317-29. PubMed ID: 15883203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
    Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
    Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
    Wei D; Le X; Zheng L; Wang L; Frey JA; Gao AC; Peng Z; Huang S; Xiong HQ; Abbruzzese JL; Xie K
    Oncogene; 2003 Jan; 22(3):319-29. PubMed ID: 12545153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
    Reisinger K; Kaufmann R; Gille J
    J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1.
    Liang X; Li ZL; Jiang LL; Guo QQ; Liu MJ; Nan KJ
    Int J Oncol; 2014 Jun; 44(6):1989-97. PubMed ID: 24647869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.